Iasis Molecular
Antimicrobial solutions company developing technologies to fight the threat of antibiotic resistant bacteria.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
$1.3m | Grant | ||
| Total Funding | 000k | ||
Related Content
IASIS Molecular Sciences focuses on developing and delivering innovative antimicrobial solutions to combat the growing threat of antibiotic resistance. The company operates in the medical, clinical, consumer, and industrial markets, providing bactericidal and fungicidal products that can be incorporated into various materials such as medical devices and work surfaces. IASIS Molecular Sciences serves healthcare providers, industrial manufacturers, and consumers who require effective and eco-conscious solutions to prevent infections and environmental microbial threats.
The business model revolves around the discovery, development, and commercialization of advanced chemistries that impede the transmission of infectious diseases and environmental fouling. Revenue is generated through the sale of these antimicrobial products to a diverse client base, including hospitals, clinics, and industrial facilities.
Keywords: antimicrobial, bactericidal, fungicidal, medical devices, clinical surfaces, industrial applications, antibiotic resistance, eco-conscious, infection prevention, healthcare.